It was also reported that increased LPA signaling during obesity promotes breast cancer progression [83], suggesting that upregulation of the ATX-LPA signaling axis could promote a variety of other obesity-related comorbidities. The gene discussed is ENPP2; the disease is obesity due to melanocortin 4 receptor deficiency.